首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1747278

预防医学市场：按服务类型、疾病领域、年龄层、交付方式、最终用户和地区划分

Preventive Medicine Market, By Service Type, By Disease Area, By Age Group, By Mode of Delivery, By End User, By Geography

出版日期: 2025年05月16日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年全球预防保健市场规模为 4.394 亿美元，到 2032 年将达到 6.307 亿美元，2025 年至 2032 年的复合年增长率为 5.3%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	4.394亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	5.30%	2032年价值预测	6.307亿美元

近年来，随着人们越来越意识到疾病预防和早期发现的重要性，全球预防性医疗保健市场取得了显着成长。预防性医疗保健着重于采取积极措施预防疾病发生并促进整体健康和福祉。这种方法涵盖了广泛的策略，包括健康体检、疫苗接种、改变生活方式和风险评估。市场的成长归因于多种因素，包括慢性病盛行率上升、老年人口成长以及对降低医疗成本的日益重视。此外，诊断工具的技术进步和创新预防疗法的开发正在推动市场的扩张。随着全球各国政府和医疗机构意识到预防性医疗保健的长期益处，预计未来对预防性医疗保健解决方案的需求将保持上升趋势。

市场动态：

全球预防性医疗保健市场受到多种关键驱动因素、市场限制因素和市场机会的影响。其中一个关键驱动因素是心血管疾病、糖尿病和癌症等慢性疾病的盛行率不断上升。这些疾病的负担日益加重，导致人们更加重视早期发现和预防，从而刺激了对预防性医疗保健解决方案的需求。此外，全球老年人口的成长进一步推动了市场成长，因为老年人更容易患慢性疾病，需要定期进行预防性医疗保健。然而，预防性医疗保健技术高成本以及某些地区对预防性医疗保健益处的认识较低等因素也限制了市场的发展。

此外，一些国家对预防性医疗保健服务的限制性报销政策也可能阻碍市场成长。儘管存在这些挑战，但市场仍提供了巨大的成长和创新机会。穿戴式装置和远端医疗等数位医疗技术的日益普及，为远距监控和个人化预防性医疗保健开闢了新的途径。此外，基因检测和生物标记分析等先进诊断工具的开发，使得风险评估和有针对性的预防干预措施更加准确。随着各国政府和医疗机构持续重视预防性医疗保健，并向预防性医疗保健计画投入资源，未来几年市场可能会大幅成长。

本研究的主要特点

本报告对全球预防性医疗保健市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（百万美元）和年复合成长率（CAGR%），假设 2024 年为基准年。
它还强调了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
全球预防性医疗保健市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球预防医学市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球预防药物市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 439.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.30%	2032 Value Projection:	USD 630.7 Mn

The global preventive medicine market has witnessed significant growth in recent years, driven by the increasing awareness about the importance of disease prevention and early detection. Preventive medicine focuses on the proactive measures taken to prevent the occurrence of diseases and promote overall health and well-being. This approach encompasses a wide range of strategies, including health screenings, vaccinations, lifestyle modifications, and risk assessment. The market's growth can be attributed to several factors, such as the rising prevalence of chronic diseases, the increasing elderly population, and the growing emphasis on reducing healthcare costs. Additionally, technological advancements in diagnostic tools and the development of innovative preventive therapies have further fueled the market's expansion. As governments and healthcare organizations worldwide recognize the long-term benefits of preventive care, the demand for preventive medicine solutions is expected to continue its upward trajectory in the coming years.

Market Dynamic:

The global preventive medicine market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and cancer. The rising burden of these diseases has led to a greater emphasis on early detection and prevention, fueling the demand for preventive medicine solutions. Moreover, the growing elderly population worldwide has further accelerated the market's growth, as older individuals are more susceptible to chronic conditions and require regular preventive care. However, the market also faces certain restraints, such as the high costs associated with preventive medicine technologies and the lack of awareness about the benefits of preventive care in some regions.

Additionally, limited reimbursement policies for preventive services in certain countries may hinder the market's growth. Despite these challenges, the market presents significant opportunities for growth and innovation. The increasing adoption of digital health technologies, such as wearable devices and telemedicine, has opened up new avenues for remote monitoring and personalized preventive care. Furthermore, the development of advanced diagnostic tools, such as genetic testing and biomarker analysis, has enabled more accurate risk assessment and targeted preventive interventions. As governments and healthcare organizations continue to prioritize preventive care and allocate resources towards preventive medicine initiatives, the market is poised for substantial growth in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global preventive medicine market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global preventive medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, AstraZeneca, Bayer AG, Becton, Dickinson and Company (BD), bioMerieux, Bristol Myers Squibb, Danaher Corporation, GlaxoSmithKline (GSK), Merck & Co Inc, Novartis, Pfizer, Roche Holding AG, Sanofi, Siemens Healthineers, and Quest Diagnostics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global preventive medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive medicine market

Market Segmentation

Service Type Insights
- Screening & Early Detection
- Vaccination & Immunizatio
- Preventive Drug Therapies
- Wellness & Lifestyle Interventions
- Digital Health & Remote Monitoring Services
Disease Area Insights
- Cardiovascular Diseases
- Cancer
- Diabetes
- Infectious Diseases
- Respiratory Diseases
- Mental Health
- Neurological Disorders
- Osteoporosis
- Others
Age Group Insights
- Pediatric
- Adult
- Geriatric
Mode of Delivery Insights
- On-site/In-Person Delivery
- Remote/Virtual Delivery
End User Insights
- Hospitals & Clinics
- Diagnostic Centers
- Government Organizations
- Private Healthcare Providers
- Employers
- Individuals (Self-Care)
Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Abbott Laboratories
- AstraZeneca
- Bayer AG
- Becton, Dickinson and Company (BD)
- bioMerieux
- Bristol Myers Squibb
- Danaher Corporation
- GlaxoSmithKline (GSK)
- Merck & Co Inc
- Novartis
- Pfizer
- Roche Holding AG
- Sanofi
- Siemens Healthineers
- Quest Diagnostics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Preventive Medicine Market, By Service Type
- Global Preventive Medicine Market, By Disease Area
- Global Preventive Medicine Market, By Age Group
- Global Preventive Medicine Market, By Mode of Delivery
- Global Preventive Medicine Market, By End User
- Global Preventive Medicine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Preventive Medicine Market, By Service Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Screening & Early Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Vaccination & Immunization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Preventive Drug Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Wellness & Lifestyle Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Digital Health & Remote Monitoring Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Preventive Medicine Market, By Disease Area, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Respiratory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mental Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Preventive Medicine Market, By Age Group, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Preventive Medicine Market, By Mode of Delivery, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
On-site/In-Person Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Remote/Virtual Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Preventive Medicine Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Government Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Private Healthcare Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Employers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Individuals (Self-Care)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Preventive Medicine Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
bioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

预防医学市场：按服务类型、疾病领域、年龄层、交付方式、最终用户和地区划分